AOD-9604: an analytical study is not a weight-loss trial

Evidence discussed: Analytical laboratory study.

What the researchers studied

This paper focused on identifying AOD9604 and its breakdown products. Researchers developed a urine-testing method and examined metabolites after incubation in serum and urine. One fragment was more stable than the parent compound, making it useful for detection research. [1]

How to interpret the result

The experiment did not test weight loss, health outcomes or self-administration safety. Proposed biological activity mentioned as background is different from an outcome demonstrated by the experiment.

What readers can take from it

The selected paper explains identity and metabolism. A validated detection method is not a validated treatment or a test of a particular commercial batch.

This original editorial summary provides no diagnosis, dosing or treatment advice. The study did not test or certify a PeptiKing product.

Source

[1] Detection and in-vitro metabolism of AOD9604 (2014). PMID: 25208511. Based on the PubMed-indexed abstract and record; full-text methods were not independently reviewed.